Ziporyn, T. A growing industry and menace: Makeshift laboratory’s designer drugs. JAMA, 12 Dec 1986, 256 (22), 3061–3063. 486 kB. https://doi.org/10.1001/jama.1986.03380220011003
Cooper, D; Jacob, M; Allen, A. Identification of fentanyl derivatives. J. Forensic Sci., 1 Apr 1986, 31 (2), 511–528. 476 kB. https://doi.org/10.1520/JFS12283J #23 GC,MS,NMR,IR
Kronstrand, R; Guerrieri, D; Vikingsson, S; Wohlfarth, A; Gréen, H. Fatal poisonings associated with new psychoactive substances. In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 495–541. 477 kB. https://doi.org/10.1007/164_2018_110 #ortho-Fluorofentanyl
Kraemer, M; Boehmer, A; Madea, B; Maas, A. Death cases involving certain new psychoactive substances: A review of the literature. Forensic Sci. Int., 1 May 2019, 298, 186–267. 6.7 MB. https://doi.org/10.1016/j.forsciint.2019.02.021 #ortho-Fluorofentanyl
Wilde, M; Pichini, S; Pacifici, R; Tagliabracci, A; Busardò, FP; Auwärter, V; Solimini, R. Metabolic pathways and potencies of new fentanyl analogs. Front. Pharmacol., 5 Apr 2019, 10 (238). 1.5 MB. https://doi.org/10.3389/fphar.2019.00238 #ortho-Fluorofentanyl
Anon. INCB: Fentanyl-related substances with no known legitimate use. 24 Jun 2018, n/a. 189 kB. #3
Åstrand, A; Guerrieri, D; Vikingsson, S; Kronstrand, R; Green, H. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects. Forensic Sci. Int., 1 Dec 2020, 317, 110553. 1.7 MB. https://doi.org/10.1016/j.forsciint.2020.110553 #2-fluorofentanyl